Trium Capital’s Verona Pharma VRNA Stock Holding History

Trium Capital’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-99,837	Closed	-$10.7M	–	67
2025 Q3	$10.7M	Buy	+99,837	New	+$10.4M	4.17%	9

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Trium Capital's VRNA Position: Q4 2025 in Review

Trium Capital sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 99,837 shares — an estimated $10.7M sold.

Trium Capital first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $10.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Trium Capital reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Trium Capital sold 99,837 Verona Pharma shares in Q4 2025, an estimated $10.7M.
Trium Capital first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Trium Capital's Verona Pharma position peaked at $10.7M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Trium Capital's 13F filing for Q4 2025, filed 22 Jan 2026.